Form 4: BridgeBio Pharma CEO Neil Kumar Reports Stock Transactions
SEC Form 4 Filing
CEO Neil Kumar reports stock transactions including acquisition from RSU vesting, tax withholding, and sales under a 10b5-1 plan.
Summary
- Neil Kumar, CEO of BridgeBio Pharma, reported several transactions involving the company's common stock.
- On May 16, 2025, 64,696 shares were acquired through the vesting of Restricted Stock Units (RSUs).
- Also on May 16, 2025, 32,854 shares were withheld to cover tax obligations related to the RSU vesting at a price of $33.84.
- Between May 19 and May 20, 2025, a total of 75,756 shares were sold under a pre-arranged Rule 10b5-1 sales plan at weighted average prices ranging from $33.3229 to $33.7475.
- Following these transactions, Kumar directly owns 217,404 shares and indirectly owns 4,798,447 shares through the Kumar Haldea Revocable Trust and 995,686 shares through the Kumar Haldea Family Irrevocable Trust.
- Kumar also holds 173,307 RSUs.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions, which are part of normal executive compensation and pre-planned sales.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market from the sales.
Key Dates
| Date | Description |
|---|---|
| 03/22/2024 | Rule 10b5-1 sales plan adopted by the Reporting Person |
| 05/16/2023 | RSUs vested with respect to 1/16th of the underlying shares |
| 05/16/2024 | RSUs vested with respect to 1/16th of the underlying shares |
| 05/16/2025 | RSUs vested with respect to 1/16th of the underlying shares; acquisition of 64,696 shares; tax withholding of 32,854 shares |
| 05/19/2025 | Sale of 26,156 shares under Rule 10b5-1 plan |
| 05/20/2025 | Sale of 75,000 shares under Rule 10b5-1 plan |
Keywords
BridgeBio Pharma, BBIO, Neil Kumar, Form 4, Stock Transactions, Restricted Stock Units, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.